Strs Ohio Cidara Therapeutics, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$1.87 - $2.7 $57,970 - $83,700	-31,000 Closed	0 $0
Q3 2020 Dec 14, 2020	BUY	$2.85 - $4.1 $41,610 - $59,859	14,600 Added 89.02%	31,000 $88,000
Q2 2020 Jul 23, 2020	BUY	$2.39 - $4.0 $39,196 - $65,600	16,400 New	16,400 $60,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $837M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.